Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptidylprolyl isomerase A pseudogene 41 (PPIAP41) is a DNA sequence related to the PPIA gene (encoding cyclophilin A), classified as a pseudogene. Unlike its protein-coding parent, PPIAP41 does not produce a functional protein and is not recognized as a direct therapeutic target. While some pseudogenes can act as long non-coding RNAs with regulatory functions or serve as competitive endogenous RNAs sponging miRNAs, there is no documented evidence or research specifically characterizing PPIAP41’s biological role, therapeutic relevance, or disease associations. As such, PPIAP41's main classification in genomic databases is as a non-coding pseudogene, and it is not considered a classical target in drug discovery[5][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidylprolyl isomerase A pseudogene 41 (PPIAP41).